These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 32820807)

  • 21. Bacterial Coinfections in Coronavirus Disease 2019.
    Westblade LF; Simon MS; Satlin MJ
    Trends Microbiol; 2021 Oct; 29(10):930-941. PubMed ID: 33934980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacterial and viral infections among adults hospitalized with COVID-19, COVID-NET, 14 states, March 2020-April 2022.
    Shah MM; Patel K; Milucky J; Taylor CA; Reingold A; Armistead I; Meek J; Anderson EJ; Weigel A; Reeg L; Como-Sabetti K; Ropp SL; Muse A; Bushey S; Shiltz E; Sutton M; Talbot HK; Chatelain R; Havers FP;
    Influenza Other Respir Viruses; 2023 Mar; 17(3):e13107. PubMed ID: 36875205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacterial Pneumonia and Respiratory Culture Utilization among Hospitalized Patients with and without COVID-19 in a New York City Hospital.
    Weidmann MD; Berry GJ; Zucker JE; Huang S; Sobieszczyk ME; Green DA
    J Clin Microbiol; 2022 Jul; 60(7):e0017422. PubMed ID: 35642519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A multicenter analysis of the clinical microbiology and antimicrobial usage in hospitalized patients in the US with or without COVID-19.
    Puzniak L; Finelli L; Yu KC; Bauer KA; Moise P; De Anda C; Vankeepuram L; Sepassi A; Gupta V
    BMC Infect Dis; 2021 Feb; 21(1):227. PubMed ID: 33639862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibiotic-Resistant Infections Among Inpatients with Coronavirus Disease 2019 (COVID-19) in US Hospitals.
    Baggs J; Rose AN; McCarthy NL; Wolford H; Srinivasan A; Jernigan JA; Reddy SC
    Clin Infect Dis; 2022 Oct; 75(Suppl 2):S294-S297. PubMed ID: 35779273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COVID-19 Outcomes Among Persons Living With or Without Diagnosed HIV Infection in New York State.
    Tesoriero JM; Swain CE; Pierce JL; Zamboni L; Wu M; Holtgrave DR; Gonzalez CJ; Udo T; Morne JE; Hart-Malloy R; Rajulu DT; Leung SJ; Rosenberg ES
    JAMA Netw Open; 2021 Feb; 4(2):e2037069. PubMed ID: 33533933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stewardship Prompts to Improve Antibiotic Selection for Urinary Tract Infection: The INSPIRE Randomized Clinical Trial.
    Gohil SK; Septimus E; Kleinman K; Varma N; Avery TR; Heim L; Rahm R; Cooper WS; Cooper M; McLean LE; Nickolay NG; Weinstein RA; Burgess LH; Coady MH; Rosen E; Sljivo S; Sands KE; Moody J; Vigeant J; Rashid S; Gilbert RF; Smith KN; Carver B; Poland RE; Hickok J; Sturdevant SG; Calderwood MS; Weiland A; Kubiak DW; Reddy S; Neuhauser MM; Srinivasan A; Jernigan JA; Hayden MK; Gowda A; Eibensteiner K; Wolf R; Perlin JB; Platt R; Huang SS
    JAMA; 2024 Jun; 331(23):2018-2028. PubMed ID: 38639723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Invasive Pneumococcal Disease and Risk of Pneumococcal Coinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Prospective National Cohort Study, England.
    Amin-Chowdhury Z; Aiano F; Mensah A; Sheppard CL; Litt D; Fry NK; Andrews N; Ramsay ME; Ladhani SN
    Clin Infect Dis; 2021 Mar; 72(5):e65-e75. PubMed ID: 33196783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trends in Empiric Broad-Spectrum Antibiotic Use for Suspected Community-Onset Sepsis in US Hospitals.
    Rhee C; Chen T; Kadri SS; Lawandi A; Yek C; Walker M; Warner S; Fram D; Chen HC; Shappell CN; DelloStritto L; Klompas M;
    JAMA Netw Open; 2024 Jun; 7(6):e2418923. PubMed ID: 38935374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia.
    Chong WH; Saha BK; Ananthakrishnan Ramani ; Chopra A
    Infection; 2021 Aug; 49(4):591-605. PubMed ID: 33709380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of a multiplex PCR screening approach to identify community-acquired bacterial co-infections in COVID-19: a multicenter prospective cohort study of the German competence network of community-acquired pneumonia (CAPNETZ).
    Rothe K; Spinner CD; Panning M; Pletz MW; Rohde G; Rupp J; Witzenrath M; Erber J; Eberhardt F; Essig A; Schneider J;
    Infection; 2021 Dec; 49(6):1299-1306. PubMed ID: 34687426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Characteristics and Outcome of Hospitalized COVID-19 Patients in a MERS-CoV Endemic Area.
    Barry M; AlMohaya A; AlHijji A; Akkielah L; AlRajhi A; Almajid F; Alsharidi A; Al-Shahrani FS; Alotaibi NH; Alanazi A; Ghonem L; Alhetheel A; Alsubaie S; Memish ZA
    J Epidemiol Glob Health; 2020 Sep; 10(3):214-221. PubMed ID: 32954712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of SARS-CoV-2 status and antibiotic-resistant bacteria with inadequate empiric therapy in hospitalized patients: a US multicenter cohort evaluation (July 2019 - October 2021).
    Bauer KA; Puzniak LA; Yu KC; Klinker KP; Watts JA; Moise PA; Finelli L; Gupta V
    BMC Infect Dis; 2023 Jul; 23(1):490. PubMed ID: 37488478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coronavirus disease 2019 (COVID-19) associated bacterial coinfection: Incidence, diagnosis and treatment.
    Wu HY; Chang PH; Chen KY; Lin IF; Hsih WH; Tsai WL; Chen JA; Lee SS;
    J Microbiol Immunol Infect; 2022 Dec; 55(6 Pt 1):985-992. PubMed ID: 36243668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibiotic use in patients with Coronavirus disease 2019 (COVID-19): outcomes and associated factors.
    Milas S; Poncelet A; Buttafuoco F; Pardo A; Lali SE; Cherifi S
    Acta Clin Belg; 2022 Jun; 77(3):579-587. PubMed ID: 33896399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recommendations for antibacterial therapy in adults with COVID-19 - an evidence based guideline.
    Sieswerda E; de Boer MGJ; Bonten MMJ; Boersma WG; Jonkers RE; Aleva RM; Kullberg BJ; Schouten JA; van de Garde EMW; Verheij TJ; van der Eerden MM; Prins JM; Wiersinga WJ
    Clin Microbiol Infect; 2021 Jan; 27(1):61-66. PubMed ID: 33010444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patterns, Predictors, and Intercenter Variability in Empiric Gram-Negative Antibiotic Use Across 928 United States Hospitals.
    Goodman KE; Baghdadi JD; Magder LS; Heil EL; Sutherland M; Dillon R; Puzniak L; Tamma PD; Harris AD
    Clin Infect Dis; 2023 Feb; 76(3):e1224-e1235. PubMed ID: 35737945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Empirical Anti-MRSA vs Standard Antibiotic Therapy and Risk of 30-Day Mortality in Patients Hospitalized for Pneumonia.
    Jones BE; Ying J; Stevens V; Haroldsen C; He T; Nevers M; Christensen MA; Nelson RE; Stoddard GJ; Sauer BC; Yarbrough PM; Jones MM; Goetz MB; Greene T; Samore MH
    JAMA Intern Med; 2020 Apr; 180(4):552-560. PubMed ID: 32065604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Retrospective Study of Coinfection of SARS-CoV-2 and Streptococcus pneumoniae in 11 Hospitalized Patients with Severe COVID-19 Pneumonia at a Single Center.
    Rodriguez-Nava G; Yanez-Bello MA; Trelles-Garcia DP; Chung CW; Egoryan G; Friedman HJ
    Med Sci Monit; 2020 Nov; 26():e928754. PubMed ID: 33188161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bacterial infections and patterns of antibiotic use in patients with COVID-19.
    Goncalves Mendes Neto A; Lo KB; Wattoo A; Salacup G; Pelayo J; DeJoy R; Bhargav R; Gul F; Peterson E; Albano J; Patarroyo-Aponte G; Rangaswami J; Azmaiparashvili Z
    J Med Virol; 2021 Mar; 93(3):1489-1495. PubMed ID: 32808695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.